MECHANISM OF CYTOKINE INDUCED B CELL DIFFERENTIATION
细胞因子诱导B细胞分化的机制
基本信息
- 批准号:6055642
- 负责人:
- 金额:$ 26.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The long term goal of this project is to understand the mechanism that
underlies differentiation and cell cycle control during terminal
differentiation of B cells to plasma cells. In vivo, terminal
differentiation of B cells is characterized by increases in Ig synthesis
and secretion, reduction in surface Ig and MHC class H expression,
morphological maturation and cell cycle arrest. Despite this knowledge,
the underlying mechanism is not well understood. Interluekin-6 (IL-6)
has a physiologic role in late stage B cell differentiation, as evident
by the development of plasmacytosis in transgenic mice overexpressing
IL-6 and by the deficiencies in secondary Ig responses in IL-6-deficient
mice. We have shown that stimulation of human B lymphoblastoid cells
with IL-6 in vitro recapitulates the major hallmarks of B cell terminal
differentiation in vivo. The objective of this proposal is to elucidate
the mechanism by which IL-6 signals are transduced to regulate Ig
synthesis in B cells.
The IL-6 signals are thought to be transduced by two
pathways: the rapid and transient JakStat pathway involving
activation of the latent transcription factors Stat3 and
Statl, and a more stable NF-IL6 pathway involying the basic-
leucine zipper transcription factor NF-IL6. Despite this
wealth of information, two crucial issues remain unresolved.
One concerns the relationship between the two pathways and
the other the determination of the promoter specificity in
each pathway. Based on our preliminary studies, we
hypothesize that the transient Jak-Stat pathway and the
stable NF-IL6 pathways are functionally coupled for
physiologic responses to IL-6 by sequential activation of
NF-IL6, which activates and inhibits downstream genes
according to the ratio of NF-IL6 isoforms and by
dimerization between NF-IL6 and Jun. To test this
hypothesis, we propose to (l) elucidate the coupling between
the Jak-Stat pathway and the NF-IL6 pathway, by determining
the requirement of Stat3 and Statl and serine
phosphorylation for the immediate activation of the NF-IL-6
promoter, (2) determine the roles of NF-IL6 and Jun in
stable IL-6 signaling, and (3) investigate the physiologic
roles of NF-IL6 isoforms in the regulation of Ig - synthesis
by studying the activation and inhibition of Ig promoters by
NF-IL6 isoforms in vitro and in vivo. These studies should
provide significant insight into the the mechanisms that
underlie cytokine signaling in the immune system and
terminal differentiation of B cells.
这个项目的长期目标是了解
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SELINA Y CHEN-KIANG其他文献
SELINA Y CHEN-KIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SELINA Y CHEN-KIANG', 18)}}的其他基金
Mechanism-Based Targeting of Mantle Cell Lymphoma
基于机制的套细胞淋巴瘤靶向治疗
- 批准号:
10478980 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Mechanism-Based Targeting of Mantle Cell Lymphoma
基于机制的套细胞淋巴瘤靶向治疗
- 批准号:
10006513 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Project 1: Therapeutic targeting of CDK4 in Mantle Cell Lymphoma
项目1:套细胞淋巴瘤中CDK4的治疗靶向
- 批准号:
10249086 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Chromatin remodeling and FOXO in targeting CDK4 in mantle cell lymphoma
染色质重塑和 FOXO 在套细胞淋巴瘤中靶向 CDK4
- 批准号:
9524114 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Mechanism-Based Targeting of Mantle Cell Lymphoma
基于机制的套细胞淋巴瘤靶向治疗
- 批准号:
10249085 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Project 1: Therapeutic targeting of CDK4 in Mantle Cell Lymphoma
项目1:套细胞淋巴瘤中CDK4的治疗靶向
- 批准号:
10006519 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
Project 1: Therapeutic targeting of CDK4 in Mantle Cell Lymphoma
项目1:套细胞淋巴瘤中CDK4的治疗靶向
- 批准号:
10478981 - 财政年份:2018
- 资助金额:
$ 26.55万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 26.55万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 26.55万 - 项目类别: